July 5, 2007 – The FDA has cleared Spectranetics Corp. to market its TURBO-Booster product for the treatment of arterial stenoses and occlusions in the leg, a peripheral laser catheter that functions as a guiding catheter facilitating directed ablation of blockages in the main arteries at or above the knee.

July 3, 2007 - Ivivi Technologies Inc., a non-invasive, electrotherapeutic technology developer, announced that it has completed enrollment of 30 patients participating in a double-blind, randomized, placebo-controlled clinical trial utilizing its pulsed electromagnetic field (PEMF) technology to treat patients with ischemic cardiomyopathies conducted at The Cleveland Clinic Florida.

July 3, 2007 - Vascular Solutions Inc. announced that the FDA has granted 510(k) clearance for the Gopher support catheter, a catheter designed to assist in the passage of interventional devices through arterial lesions by utilizing a rotational force.
The Gopher catheter is designed designed to meet specific needs of physicians performing interventional percutaneous procedures in coronary and peripheral arteries, such as facilitating the passing of an angioplasty balloon in challenging coronary interventions.

July 3, 2007 - CryoCor, Inc. and Boston Scientific Corporation announced on June 28 a strategic collaboration in the field of cryoablation for treating cardiac arrhythmias, in which they will co-develop therapeutic solutions for atrial fibrillation, or Afib.

July 3, 2007 - TeraRecon, Inc. announced that Fovia and certain persons now or previously associated with it agreed to pay undisclosed but significant sums, including royalty payments relating to past activities and royalties on future activities to TeraRecon, to settle a lawsuit pertaining to 3-D imaging technology filed by TeraRecon against Fovia and certain employees in October of 2005.

July 2, 2007 - New research published in the July issue of the Journal of Vascular Surgery indicates that arterial blockages in legs from peripheral arterial disease (PAD) represent such a high burden of atherosclerotic plaque that they may cause the blood flowing through "diseased" territory to become more "thick" and prone to form clots.

Vascular Solutions Inc. announced that the FDA has granted 510(k) clearance for the Gopher support catheter, a catheter designed to assist in the passage of interventional devices through arterial lesions by utilizing a rotational force.

The Gopher catheter is designed designed to meet specific needs of physicians performing interventional percutaneous procedures in coronary and peripheral arteries, such as facilitating the passing of an angioplasty balloon in challenging coronary interventions.

July 2, 2007 — Spectrum Surgical Instruments Corp. recently announced their assortment package of surgical instrument tip protectors.

The assortment includes many sizes and colors and can be used for general instruments, verres needles and laparoscopic instruments.

Spectrum’s tip protectors are completely latex free. Patterns can be reordered individually and are available in vented and non-vented styles.

For more information: www.spectrumsurgical.com

June 29, 2007 - Investigators from the Wake Forest University (WFU) School of Medicine in Winston-Salem N.C. and University of California at San Francisco report that debris liberated during angioplasty and stenting of the kidney arteries may harm kidney function.

June 29, 2007 – St. Jude Medical, Inc. today announced that the FDA and European CE Mark approvals to expand the capabilities of its Frontier II cardiac resynchronization therapy pacemaker (CRT-P) to include QuickOpt Timing Cycle Optimization, designed to provide physicians a new option to manage therapy for patients based on their individual needs.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now